Tell me in detail about spinal anaesthesia

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Loading Image
Finding Sources
Reading File
I now have a thorough evidence base from multiple premium anaesthesia textbooks. Let me compose the detailed answer.

Spinal Anaesthesia - A Detailed Overview

Spinal anaesthesia (also called subarachnoid block, SAB, or intrathecal anaesthesia) is the injection of a local anaesthetic - with or without adjuvants - directly into the cerebrospinal fluid (CSF) in the subarachnoid space, producing rapid, dense, and predictable sensory and motor blockade below the level of injection.

1. Anatomy Relevant to Spinal Anaesthesia

The spinal cord ends at L1-L2 in adults (lower in neonates - up to L3). Below this level, the subarachnoid space contains only the cauda equina nerve roots floating in CSF. Spinal injections are therefore performed at L2-L3, L3-L4, or L4-L5 interspaces to avoid cord injury.
Layers traversed during needle insertion (midline approach):
  1. Skin and subcutaneous fat
  2. Supraspinous ligament
  3. Interspinous ligament
  4. Ligamentum flavum
  5. Epidural space
  6. Posterior dura mater
  7. Subdural space (potential)
  8. Arachnoid mater
  9. Subarachnoid space (target - contains CSF)
The characteristic "click" or "pop" felt as the needle penetrates the dura signals entry into the subarachnoid space. CSF flows back freely once the stylet is removed.
The intercristal (Tuffier's) line - connecting the iliac crests - typically corresponds to the L4-L5 interspace, though ultrasonographic studies show this landmark can be unreliable.

2. Indications

Spinal anaesthesia is suitable for nearly all procedures at or below the umbilicus (T10 level) and many infradiaphragmatic procedures:
CategoryProcedures
UrologicTURP, cystoscopy, nephrolithotomy
GynaecologicHysterectomy, D&C, tubal ligation
ObstetricCaesarean section (most common indication; preferred over GA), operative vaginal delivery (saddle block)
OrthopaedicTotal hip/knee arthroplasty, hip fracture repair, ankle surgery
Lower abdominalInguinal hernia repair, appendicectomy
Perineal/rectalHaemorrhoidectomy, anal surgery
VascularFemoral-popliteal bypass
Spinal anaesthesia is the preferred technique for most elective Caesarean sections because it avoids airway manipulation, provides faster onset than epidural, has a denser block, and avoids the maternal mortality risks associated with general anaesthesia (failed intubation, aspiration).
  • Sabiston Textbook of Surgery, p. 1572; Miller's Anesthesia 10e, p. 6044

3. Contraindications

Absolute:
  • Patient refusal
  • Sepsis or bacteraemia
  • Infection at the injection site
  • Severe hypovolemia / haemodynamic instability
  • Coagulopathy or therapeutic anticoagulation
  • Raised intracranial pressure (risk of brainstem herniation from caudal CSF loss)
  • Allergy to local anaesthetics
Relative:
  • Pre-existing neurological disease (controversial)
  • Previous spine surgery or abnormal spinal anatomy
  • Demyelinating disorders (MS) - not an absolute contraindication depending on context
  • Severe aortic stenosis or fixed cardiac output states
  • Patient unable to cooperate or remain still
  • Sabiston Textbook of Surgery, p. 1605; Morgan & Mikhail, Key Concepts

4. Drugs Used

Local Anaesthetics

DrugTypeDose (adult)DurationNotes
Bupivacaine 0.5%Amide7.5-15 mg90-150 minMost widely used; isobaric or hyperbaric forms
RopivacaineAmide15-22.5 mg~120 minSimilar to bupivacaine; slightly less cardiotoxic
Lidocaine 5%Amide50-100 mg60-90 minFaster onset; associated with TNS - largely abandoned
Prilocaine 2%Amide40-60 mg100-130 minRarely associated with TNS; used in ambulatory surgery
MepivacaineAmide30-80 mg120-180 minShorter-acting than bupivacaine; earlier ambulation
TetracaineEster5-20 mgUp to 5 hr (with vasoconstrictor)Long-acting; needs additive
Chloroprocaine 3%Ester30-60 mg45-60 minShort-acting; used in ambulatory procedures
  • Miller's Anesthesia 10e, pp. 6056-6063

Opioid Adjuvants

Small doses of intrathecal opioids significantly improve block quality, duration of analgesia, and tolerance for tourniquet pain:
  • Fentanyl 10-30 mcg: lipophilic, rapid onset (10-20 min), duration 4-6 hrs; used in ambulatory surgery
  • Sufentanil 5-7.5 mcg: potent lipophilic opioid for obstetric spinal
  • Morphine 0.1-0.3 mg: hydrophilic, delayed onset but very prolonged analgesia (12-24 hrs); risk of delayed respiratory depression; useful post-op
  • Diamorphine (heroin) 0.3-0.4 mg: used in the UK instead of morphine for Caesarean section
  • Miller's Anesthesia 10e, p. 6060-6061

Vasoconstrictors

  • Epinephrine 0.1-0.2 mg: reduces systemic uptake of local anaesthetic via α1 vasoconstriction; prolongs short-acting agents; also has direct α2-mediated analgesic effect
  • Phenylephrine 2-5 mg: prolongs lidocaine and tetracaine; associated with TNS when combined with tetracaine

Other Adjuvants

  • Clonidine (α2-agonist): prolongs block duration and improves intraoperative quality
  • Neostigmine: intrathecal use is experimental; associated with nausea/vomiting

5. Factors Affecting Block Height and Spread

Drug Factors

  1. Baricity (most important): ratio of local anaesthetic density to CSF density (CSF density = 1.00059 g/mL at 37°C)
    • Hyperbaric: denser than CSF (dextrose added); spreads to dependent regions; more predictable
    • Hypobaric: lighter than CSF (water added); spreads to non-dependent regions; useful for prone positioning
    • Isobaric: same density as CSF; not significantly influenced by gravity
  2. Dose: higher dose = greater cephalad spread and longer duration
  3. Volume: larger volume = turbulent flow = unpredictable spread (inject slowly ~0.2 mL/s)
  4. Speed of injection: slower is better; turbulence causes unpredictable spread
  5. Concentration: affects onset speed and motor block depth

Patient Factors

  • Position: sitting position with hyperbaric solution = preferential lumbosacral ("saddle") block; lateral position biases the block to dependent side
  • Obesity: reduces subarachnoid volume; increases cephalad spread
  • Pregnancy: engorgement of epidural veins and increased abdominal pressure compress the subarachnoid space
  • Age: elderly patients are more sensitive to intrathecal agents
  • Height: affects spinal column length; extremes may require dose adjustment
  • Spinal abnormalities: previous surgery, scoliosis, spinal stenosis can all increase or unpredictably alter spread

Dermatome Levels Required for Common Procedures

  • Caesarean section: T4
  • Upper abdominal surgery: T4-T6
  • Lower abdominal/hernia: T6-T10
  • Hip surgery: T10
  • Lower extremity/knee: T10-T12
  • Perineal/anal: S2-S4 (saddle block)
  • Miller's Anesthesia 10e, p. 6044-6045

6. Technique

Patient Preparation

  • Obtain informed consent
  • Establish IV access; administer crystalloid preload or co-load
  • Standard monitoring: ECG, SpO2, NIBP
  • Resuscitation equipment and vasopressors available

Positioning

Two main positions:
  1. Sitting position: patient sits upright with knees drawn up and neck flexed, accentuating lumbar kyphosis. Preferred for obese patients, hyperbaric technique for saddle block, and easier landmark identification
  2. Lateral decubitus: patient in foetal position with knees and neck flexed. Can bias the block to the dependent side with hyperbaric solution
Aseptic technique is mandatory - full sterile drape, chlorhexidine skin prep, sterile gloves.

Needle Selection

  • Pencil-point (atraumatic) needles (Whitacre 25G, Sprotte 24G, Gertie Marx) are preferred - they separate rather than cut dural fibres, significantly reducing post-dural puncture headache (PDPH)
  • Quincke (cutting) needles (22-25G) - bevel should be oriented parallel to the spine to minimise PDPH
  • Smaller gauge = longer wait for CSF return but lower PDPH risk

Midline Approach (Standard)

  1. Palpate the L3-L4 or L4-L5 interspace
  2. Raise a skin wheal of local anaesthetic at the insertion site
  3. Insert introducer (for fine gauge needles) slightly cephalad (10-15 degrees)
  4. Advance spinal needle through introducer, traversing: subcutaneous tissue → supraspinous ligament → interspinous ligament → ligamentum flavum → dura ("click/pop")
  5. Remove stylet; confirm free CSF flow
  6. Attach syringe; aspirate CSF to confirm placement
  7. Inject local anaesthetic at ~0.2 mL/s; re-aspirate 0.2 mL CSF at end to confirm and clear needle
  8. Position patient appropriately for desired block level

Paramedian Approach

  • Useful when midline calcification is present (elderly, spondylotic spines)
  • Insert 1 cm lateral to the superior edge of the inferior spinous process, angled cephalomedially 10-15 degrees off the sagittal plane
  • Does not traverse supraspinous or interspinous ligaments; bypasses calcified structures
  • Miller's Anesthesia 10e, pp. 6071-6072

7. Physiological Effects

Cardiovascular

  • Hypotension: most common side effect. Sympathetic blockade (T1-L2) causes arterial and venous vasodilation, reduced preload and afterload. Magnitude proportional to block height.
  • Bradycardia: blockade of cardioaccelerator fibres (T1-T4) reduces heart rate. Severe bradycardia or asystole can occur, especially if parasympathetic tone is unopposed.
  • Decreased cardiac output: secondary to reduced preload
Management of hypotension: IV fluids (crystalloid co-loading), left uterine displacement (in pregnancy), vasopressors (phenylephrine preferred in obstetrics; ephedrine for non-obstetric patients).

Respiratory

  • Block up to T10: no significant respiratory compromise (intercostal muscles intact)
  • Block extending to T1-T4: intercostal paralysis; accessory muscle loss; patient may report difficulty breathing but diaphragm (C3-C5) remains intact
  • Block extending to C3-C5: diaphragmatic paralysis; respiratory arrest
  • Apnoea after "high spinal" is nearly always due to brainstem ischaemia from hypotension, not direct phrenic nerve block

Gastrointestinal

  • Sympathetic block with unopposed parasympathetic (vagal) activity → increased gut motility, nausea/vomiting
  • Nausea can also result from hypotension

8. Complications

Immediate Complications

Hypotension
  • Incidence up to 80% in obstetric patients with spinal for Caesarean section
  • Treated with: phenylephrine infusion (now preferred over ephedrine in obstetrics as it causes less fetal acidosis), IV fluids, left lateral tilt, ephedrine if bradycardia coexists
  • A 2023 consensus statement recommends prophylactic phenylephrine infusion + crystalloid co-loading + left uterine displacement
Bradycardia / Asystole
  • Block of T1-T4 accelerator fibres; treat with atropine, ephedrine, or epinephrine
High / Total Spinal
  • Excessive cephalad spread causes: hypotension → bradycardia → cardiac arrest → respiratory failure → loss of consciousness
  • A total spinal is distinguished from a high spinal by intracranial spread of local anaesthetic (LOC, brainstem depression)
  • Management: immediate intubation and ventilation, aggressive vasopressor support (large doses of epinephrine may be needed), psychological reassurance until block resolves
  • Risk factors: obesity, short stature, spinal following failed epidural, high injection site
Nausea and Vomiting
  • From hypotension, unopposed vagal activity, or opioid adjuvants

Delayed Complications

Post-Dural Puncture Headache (PDPH)
  • Frontal or occipital headache, typically worse upright, relieved supine
  • Mechanism: CSF loss → traction on pain-sensitive intracranial structures, OR compensatory intracerebral vasodilation
  • Associated symptoms: nausea, vomiting, neck pain, tinnitus, diplopia, hearing loss, cranial nerve palsies
  • Onset: >90% within 3 days (66% within 48 hrs); spontaneous resolution in 72% within 7 days
  • Serious associations: cerebral venous thrombosis, subdural haematoma (aOR 19.0), bacterial meningitis (aOR 39.7)
  • Prevention: use pencil-point needles; orient cutting bevel parallel to spinal axis; smaller gauge needles
  • Treatment: bed rest, hydration, analgesics, caffeine; definitive treatment = epidural blood patch (autologous blood 15-20 mL)
  • Miller's Anesthesia 10e, p. 6115
Transient Neurological Symptoms (TNS)
  • Burning dysesthesias, pain in lower extremities/buttocks after spinal anaesthesia
  • Most common with lidocaine 5% especially in lithotomy position in male patients
  • Usually self-limiting, resolves within 4 weeks
  • Management: many now substitute chloroprocaine, mepivacaine, or low-dose bupivacaine for lidocaine
Cauda Equina Syndrome
  • Permanent neurological damage (bladder/bowel incontinence, lower limb weakness/sensory loss)
  • Associated with continuous spinal catheters + repeated high doses of 5% lidocaine causing drug pooling around cauda equina
  • Rare but devastating
Epidural Haematoma
  • Most feared serious complication
  • Risk increased by coagulopathy or anticoagulant therapy
  • Presents with back pain + progressive neurological deficit
  • Emergency MRI; surgical decompression within 6 hours if neurological compromise
Epidural Abscess / Meningitis
  • Breach of aseptic technique
  • Presents with fever, back pain, meningism, neurological deficit
  • Requires urgent imaging, antibiotics, possible surgical drainage
Urinary Retention
  • Sacral nerve block (S2-S4) inhibits detrusor contraction; common, usually resolves with block
Backache
  • Less common with spinal than epidural anaesthesia
  • Usually musculoskeletal (positioning on operating table); transient

9. Combined Spinal-Epidural (CSE) Anaesthesia

CSE combines the rapid, dense onset of spinal anaesthesia with the flexibility and controllability of epidural anaesthesia. It is particularly valuable for:
  • Labour analgesia (intrathecal opioid for rapid pain relief + epidural catheter for ongoing analgesia or conversion to surgical anaesthesia)
  • Long procedures where the spinal may wear off
  • High-risk patients where a low initial spinal dose is safer (block can be extended via epidural)
Epidural Volume Extension (EVE): injecting saline or LA into the epidural space after a low-dose spinal compresses the dural sac, increasing block height without additional intrathecal drug. This achieves comparable sensory block with faster motor recovery.
Technique: needle-through-needle (single interspace) or two-needle/two-interspace approach.
  • Miller's Anesthesia 10e, p. 6103-6104

10. Special Considerations

Obstetric Patients

  • Spinal preferred over GA for elective Caesarean section (lower maternal mortality)
  • Phenylephrine infusion is the vasopressor of choice (less fetal acidosis than ephedrine)
  • Norepinephrine is emerging as an alternative with better maintenance of cardiac output
  • Hyperbaric bupivacaine 10-12 mg + fentanyl 10-25 mcg ± epinephrine 0.1-0.2 mg is the standard regimen
  • Saddle block (hyperbaric solution + sitting position): used for operative vaginal delivery
  • Miller's Anesthesia 10e, p. 8863

Paediatric Patients

  • Spinal cord terminates lower (L3) in neonates; CSF volume relatively higher (10 mL/kg vs 1.5-2 mL/kg in adults)
  • Higher weight-based doses required (dilution effect)
  • Haemodynamically stable in young children even with high blocks
  • Main indication: inguinal hernia repair in ex-premature infants (<60 weeks post-conceptual age) who are at risk of post-GA apnoea

Anticoagulated Patients

  • ASRA guidelines (4th edition) govern the timing of neuraxial procedures relative to anticoagulants:
    • LMWH (prophylactic): wait 12 hrs; LMWH (therapeutic): wait 24 hrs
    • Warfarin: INR ≤1.4 before procedure
    • Aspirin alone: not a contraindication
    • Direct oral anticoagulants: drug-specific windows required

11. Advantages over General Anaesthesia

  • Avoids airway manipulation and risk of failed intubation
  • Less nausea and vomiting
  • Less drowsiness and prolonged emergence
  • Excellent post-operative analgesia (especially with intrathecal morphine)
  • Awake patient - useful monitor for TURP (hyponatraemia detection), and allows neurological assessment
  • Reduced intraoperative blood loss (vasodilatation effect)
  • Reduced DVT risk (lower extremity surgery)
  • Lower maternal morbidity/mortality in obstetrics
  • Possible reduction in perioperative opioid requirements

12. Disadvantages and Limitations

  • Fixed duration: single-shot spinal cannot be extended; unsuitable for procedures of uncertain length (unless CSE used)
  • Hypotension: almost inevitable for high blocks; must be proactively managed
  • PDPH: incidence ~1-5% depending on needle type
  • Failure rate: ~1-5%; requires conversion to GA
  • Limited upper extent: cannot be used for thoracic or upper abdominal surgery without very high (and therefore risky) block levels
  • Technical failure: difficult in obese, elderly (calcified ligaments), or scoliotic patients

Sources:
  • Miller's Anesthesia, 2-Volume Set, 10th Edition (primary - extensive spinal anaesthesia chapter)
  • Morgan and Mikhail's Clinical Anesthesiology, 7th Edition
  • Sabiston Textbook of Surgery
  • Barash, Cullen, and Stoelting's Clinical Anesthesia, 9th Edition

Which drug to stop when before surgery for anaesthesia

Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
I now have comprehensive, authoritative data from multiple major anaesthesia and surgery textbooks. Let me compile the complete answer.

Drugs to Stop (and When) Before Surgery / Anaesthesia

The general perioperative principle is: continue drugs whose withdrawal causes harm; stop drugs whose perioperative presence causes harm. The timing is drug-specific.

DRUGS TO STOP - With Timing

1. Antiplatelet Agents

DrugWhen to StopNotes
Aspirin3-7 days beforeContinue in patients with prior PCI, drug-eluting stent (within recommended dual-antiplatelet period), high-grade ischaemic heart disease, or significant cerebrovascular disease. Stop otherwise.
Clopidogrel5 days beforeDo NOT stop in patients with drug-eluting stents until minimum recommended dual-antiplatelet therapy duration is complete
Ticagrelor3 days beforeFaster offset than clopidogrel
Prasugrel7 days beforeLonger-acting
Ticlopidine10 days beforeLongest offset
GP IIb/IIIa inhibitors (tirofiban, eptifibatide)12+ hours beforeEffect may persist longer
  • Miller's Anesthesia 10e, Box 28.11; Mulholland & Greenfield's Surgery, Table 14.9

2. Anticoagulants

DrugWhen to StopNotes
Warfarin5 days beforeTarget INR ≤1.4 pre-procedure; bridge with LMWH/UFH if high thromboembolic risk (e.g., AF with high CHADS score, mechanical valve)
LMWH (therapeutic dose)24 hours before
LMWH (prophylactic dose)12 hours before
Rivaroxaban24-48 hours before (standard) 48-72 hrs for high-bleed proceduresDepends on renal function and bleeding risk
Apixaban24-48 hours beforeSimilar to rivaroxaban; highly protein-bound - NOT dialysable
Dabigatran48-72 hours beforeRenal-dependent clearance - longer if eGFR <50; can be removed by dialysis in emergency
Edoxaban24-48 hours before
Fondaparinux36-42 hours beforeLong half-life
The PAUSE trial showed that in AF patients on DOACs, simple interruption without bridging or coagulation testing was associated with low rates of both bleeding and thromboembolism.
  • Mulholland & Greenfield's Surgery, p. 895-897

3. Antidiabetic Medications

DrugWhen to StopReason
MetforminMorning of surgery (or 24-48 hrs before major surgery)Risk of lactic acidosis, especially with contrast or if renal perfusion compromised intraoperatively
Sulfonylureas (glibenclamide, glipizide)Morning of surgeryRisk of intraoperative hypoglycaemia when fasting
GLP-1 agonists (semaglutide, liraglutide)Morning of surgery (weekly injectables: hold for 1 week)Slow gastric emptying - increases aspiration risk
SGLT-2 inhibitors (empagliflozin, dapagliflozin, canagliflozin)At least 24 hours before elective surgery; 72 hours before intermediate/high-risk (major) surgeryRisk of euglycaemic diabetic ketoacidosis (DKA) in the postoperative period - this is a critical newer warning
DPP-4 inhibitors (sitagliptin, saxagliptin)Morning of surgeryHold while fasting
Repaglinide/nateglinideMorning of surgeryRisk of hypoglycaemia
Short-acting insulinMorning of surgery (hold while fasting)Avoid hypoglycaemia
Long-acting insulinReduce dose (not stop): Type 1 DM - give 1/3 of usual dose; Type 2 DM - give none or up to 1/2 usual doseDo NOT omit entirely in Type 1 DM - risk of DKA
Insulin pumpContinue at lowest basal (nighttime) rate
  • Miller's Anesthesia 10e, p. 3967-3968

4. ACE Inhibitors and ARBs

Drug ClassWhen to StopReason
ACEi (ramipril, enalapril, lisinopril)Morning of surgery (hold day of surgery)Inhibit angiotensin II-mediated vasoconstriction that compensates for anaesthesia-induced vasodilation → severe refractory intraoperative hypotension
ARBs (losartan, valsartan, candesartan)Morning of surgery (hold day of surgery)Same reason
Administration of ACEi/ARBs within 24 hours before surgery is associated with significantly increased risk of intraoperative hypotension.
  • Miller's Anesthesia 10e, p. 4031; Mulholland & Greenfield, Table 14.9

5. Diuretics

DrugWhen to StopNotes
Loop diuretics (furosemide, bumetanide)Morning of surgeryRisk of hypovolaemia and electrolyte imbalance
Potassium-sparing diuretics (spironolactone, amiloride)Morning of surgeryRisk of hyperkalaemia, especially with renal impairment
Thiazides (for hypertension, e.g., hydrochlorothiazide)Continue on day of surgeryException to the rule - continue for hypertension control

6. NSAIDs

DrugWhen to StopNotes
Non-selective NSAIDs (ibuprofen, diclofenac, naproxen)48-72 hours beforeReversible platelet inhibition and risk of perioperative AKI; earlier discontinuation adds no benefit
COX-2 inhibitors (celecoxib)Continue on day of surgery (usually)Minimal platelet effect; exception: stop if surgeon concerned about bone healing (orthopaedic surgery)

7. Hormonal Drugs

DrugWhen to StopReason
Oestrogen-containing HRT (postmenopausal)4 weeks before major surgeryIncreased thromboembolic (VTE) risk; 4 weeks needed for coagulation to normalise
Combined oral contraceptivesUsually continue (weigh unintended pregnancy risk vs. VTE risk)Consider stopping 4 weeks before surgery if patient is high VTE risk
Testosterone/anabolic steroids4 weeks beforePolycythaemia and VTE risk
Tamoxifen4 weeks before major surgeryHypercoagulable state
Note: Sugammadex reversal agent can reduce efficacy of hormonal contraceptives - advise additional non-hormonal contraception for 7 days after

8. Psychiatric / Neurological Drugs

DrugActionWhen/How
MAOIs (phenelzine, tranylcypromine) - irreversibleTraditionally stopped 2-3 weeks before; but current practice is often to continue and modify anaestheticRisk: serotonin syndrome with pethidine (meperidine); hypertensive crisis with indirect vasopressors (ephedrine). If continued: avoid pethidine, use direct vasopressors (phenylephrine/norepinephrine)
MAOIs (moclobemide) - reversible24 hours beforeShort-acting; much safer
LithiumHold at least 1 day beforeProlongs neuromuscular blockade; sedative interaction; risk of cardiac arrhythmia; narrow therapeutic index
SSRIs / SNRIsGenerally continueMinor increased bleeding risk; abrupt withdrawal causes discontinuation syndrome. Stop 3 weeks before only if bleeding is a major concern, in discussion with psychiatrist
AntipsychoticsContinueRisk of decompensation if stopped; QT prolongation - inform anaesthetist
AntiepilepticsContinueSeizure risk; also important as enzyme inducers (affect drug metabolism)

9. Cardiovascular Drugs

DrugAction
Beta-blockersContinue on day of surgery. Abrupt withdrawal can cause rebound hypertension, tachycardia, myocardial ischaemia. Do not start new beta-blockers immediately preoperatively (increased risk of stroke and hypotension)
DigoxinContinue
Calcium channel blockersContinue
NitratesContinue
AntiarrhythmicsContinue
StatinsContinue (even have organ-protective effects perioperatively; consider initiating in vascular surgery patients)
ClonidineContinue (abrupt withdrawal causes rebound hypertension)
Alpha-blockers (doxazosin)Continue but be aware of risk of hypotension with anaesthesia

10. Herbal Supplements and Over-the-Counter Products

These are frequently undisclosed by patients (>70% fail to mention them). Most should be stopped 7 days before surgery. Key offenders:
SupplementConcern
Garlic, ginger, ginkgo, ginseng, feverfewAntiplatelet effects - increased bleeding
St John's WortCYP450 enzyme induction - alters drug metabolism; also serotonin syndrome risk
EchinaceaImmune modulation; potential hepatotoxicity
Ephedra (Ma huang)Cardiovascular instability; dangerous with MAOIs and vasopressors
KavaSedation potentiation; hepatotoxicity
ValerianSedation; withdrawal symptoms
Fish oil / Omega-3Antiplatelet effect
Vitamin EAntiplatelet and anticoagulant

11. Phosphodiesterase-5 Inhibitors

DrugWhen to Stop
Sildenafil, tadalafil, vardenafil24 hours before surgery

12. Topical Medications (creams, ointments)

  • Stop on the day of surgery (application to skin near surgical site can cause electrosurgery complications or alter skin preparation)

DRUGS TO ALWAYS CONTINUE

These should not be stopped and should be taken with a small sip of water even when fasting:
Drug ClassReason
Beta-blockersRebound ischaemia/arrhythmia if stopped
AntiepilepticsSeizures
Antipsychotics, antidepressants (most)Psychiatric decompensation
StatinsPleiotropic cardioprotective effects
Corticosteroids (inhaled and oral)Adrenal suppression / asthma
Thyroid medicationsThyroid crisis or myxoedema
Opioids (chronic)Withdrawal syndrome
HIV antiretroviralsResistance development
Asthma inhalersBronchospasm
Eye dropsGlaucoma / IOP control
Reflux / PPI medications(Also reduces aspiration risk)

Quick Summary Table

STOPTiming
SGLT-2 inhibitors24-72 hrs before
Warfarin5 days before
Clopidogrel5 days; prasugrel 7 days; ticagrelor 3 days
NSAIDs48-72 hrs before
Metformin, sulfonylureas, GLP-1 agonists, DPP-4 inhibitorsMorning of surgery
ACEi / ARBsMorning of surgery (hold day of surgery)
Loop and K+-sparing diureticsMorning of surgery
Short-acting insulinMorning of surgery
Phosphodiesterase-5 inhibitors24 hrs before
Postmenopausal HRT (oestrogen)4 weeks before major surgery
Lithium24 hrs before
Herbal supplements7 days before
Irreversible MAOIs (if stopping)2-3 weeks before
Topical creams/ointmentsDay of surgery

Sources:
  • Miller's Anesthesia, 2-Volume Set, 10th Edition - Box 28.11, Preoperative Management of Medications, pp. 4031-4036
  • Mulholland and Greenfield's Surgery, 7th Edition - Table 14.9, pp. 895-899
  • Sabiston Textbook of Surgery
Clinical note: These are general guidelines. Always individualise management based on the patient's specific indication for the drug, the type and urgency of surgery, and bleeding/thrombotic risk balance. For anticoagulated patients, involve haematology or cardiology when appropriate.
This is a shared conversation. Sign in to Orris to start your own chat.